Disclosure under SEBI Takeover Regulations

Aurobindo Pharma Limited has announced a disclosure under Regulation 31(4) of the SEBI Takeover Regulations. Promoter K. Nithyananda Reddy, on behalf of the promoter and promoter group, declared that they have not made any new encumbrances (such as pledges) on their shares in the company during the financial year ended March 31, 2026. This declaration confirms that no additional shares were pledged beyond what was already disclosed to the stock exchanges. For investors, this signifies transparency from the promoters regarding their shareholdings, providing reassurance about the stability of their stake.